Regulation of renal fibrosis by macrophage polarization

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 1062-1069

  Pan, Bixia ^a   Liu, Guohui ^a   Jiang, Zongpei ^b   Zheng, Dongwen ^a  

^a DONGGUAN PEOPLE'S HOSPITAL   (China)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bone morphogenic protein 7 (BMP7); E cadherin; Epithelial to mesenchymal transition (EMT); Macrophages; Renal fibrosis; Transforming growth factor 1 (TGF 1); Unilateral ureteral obstruction (UUO); smooth muscle actin ( SMA)

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD163 ANTIGEN; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; BMP7 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SUBPOPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FLOW CYTOMETRY; KIDNEY FIBROSIS; KIDNEY INJURY; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; URETER OBSTRUCTION; ANIMAL; CELL CULTURE; CELL POLARITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROSIS; GENETICS; HUMAN; INJURIES; KIDNEY; KIDNEY FAILURE; KIDNEY TUBULE; METABOLISM; PATHOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL POLARITY; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; KIDNEY; KIDNEY TUBULES; MACROPHAGES; MICE; RENAL INSUFFICIENCY; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84923096359     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000373932     Document Type: Article

References (31)

1. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB: Transforming growth factor-beta-dependent and-independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 2003;163:1261-1273.
2. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of tgf-beta1/smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003;112:1486-1494.
3. Goto Y, Manabe N, Uchio-Yamada K, Yamaguchi-Yamada M, Inoue N, Yamamoto Y, Ogura A, Nagano N, Miyamoto H: Augmented cytoplasmic smad4 induces acceleration of tgf-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic icgn mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Cell Tissue Res 2004;315:209-221.
4. Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, Park KK: Tgf-beta1 sirna suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006;81:48-54.
5. Padua D, Massague J: Roles of tgfbeta in metastasis. Cell Res 2009;19:89-102.
6. Massague J, Chen YG: Controlling tgf-beta signaling. Genes Dev 2000;14:627-644.
7. Xiao X, Wiersch J, El-Gohary Y, Guo P, Prasadan K, Paredes J, Welsh C, Shiota C, Gittes GK: Tgfbeta receptor signaling is essential for inflammation-induced but not beta-cell workload-induced beta-cell proliferation. Diabetes 2013;62:1217-1226.
8. Liu FY, Li XZ, Peng YM, Liu H, Liu YH: Arkadia-smad7-mediated positive regulation of tgf-beta signaling in a rat model of tubulointerstitial fibrosis. Am J Nephrol 2007;27:176-183.
9. Wang Y, Zhang Z, Shen H, Lu Y, Li H, Ren X, Wu G: Tgf-beta1/smad7 signaling stimulates renal tubulointerstitial fibrosis induced by aai. J Recept Signal Transduct Res 2008;28:413-428.
10. Tamura M, Aizawa R, Hori M, Ozaki H: Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem Cell Biol 2009;131:483-490.
11. Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM, Tang MJ: Transforming growth factor-{beta}1 induces smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 2010;177:1743-1754.
12. Sugimoto H, Yang C, LeBleu VS, Soubasakos MA, Giraldo M, Zeisberg M, Kalluri R: Bmp-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 2007;21:256-264.
13. Zeisberg M: Bone morphogenic protein-7 and the kidney: Current concepts and open questions. Nephrol Dial Transplant 2006;21:568-573.
14. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: Bmp-7 counteracts tgf-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
15. Manucha W: Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007;31:1-12.
16. Wen JG: Partial unilateral ureteral obstruction in rats. Neurourol Urodyn 2002;21:231-250.
17. Belmiro CL, Goncalves RG, Kozlowski EO, Werneck AF, Takyia CM, Leite-Jr M, Pavao MS: Dermatan sulfate reduces monocyte chemoattractant protein 1 and tgf-beta production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Braz J Med Biol Res 2011;44:624-633.
18. Sung SA, Jo SK, Cho WY, Won NH, Kim HK: Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp Nephrol 2007;105:e1-9.
19. Naruse T, Yuzawa Y, Akahori T, Mizuno M, Maruyama S, Kannagi R, Hotta N, Matsuo S: P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction. Kidney Int 2002;62:94-105.
20. Takeda A, Fukuzaki A, Kaneto H, Ishidoya S, Ogata Y, Sasaki T, Konda R, Sakai K, Orikasa S: Role of leukocyte adhesion molecules in monocyte/macrophage infiltration in weanling rats with unilateral ureteral obstruction. Int J Urol 2000;7:415-420.
21. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
22. Gordon S, Martinez FO: Alternative activation of macrophages: Mechanism and functions. Immunity 2010;32:593-604.
23. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K: Development of monocytes, macrophages, and dendritic cells. Science 2010;327:656-661.
24. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008;118:3522-3530.
25. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, Gittes GK: M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci USA 2014;111:E1211-1220.
26. van Rooijen N, Bakker J, Sanders A: Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol 1997;15:178-185.
27. van Rooijen N, van Nieuwmegen R: Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res 1984;238:355-358.
28. Plosker GL, Goa KL: Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1994;47:945-982.
29. Kanis JA, McCloskey EV: Clodronate. Cancer 1997;80:1691-1695.
30. Wells RG: Bmp-7: A new tgf-beta family member takes the stage in colitis treatment. Inflamm Bowel Dis 2004;10:169.
31. Shen B, Liu X, Fan Y, Qiu J: Macrophages regulate renal fibrosis through modulating tgfbeta superfamily signaling. Inflammation 2014;37:2076-2084.